Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.

McArthur GA, Demetri GD, van Oosterom A, Heinrich MC, Debiec-Rychter M, Corless CL, Nikolova Z, Dimitrijevic S, Fletcher JA.

J Clin Oncol. 2005 Feb 1;23(4):866-73.

PMID:
15681532
2.

Dermatofibrosarcoma protuberans: recent clinical progress.

McArthur G.

Ann Surg Oncol. 2007 Oct;14(10):2876-86. Epub 2007 Jul 24. Review.

PMID:
17647063
3.

Molecularly targeted treatment for dermatofibrosarcoma protuberans.

McArthur G.

Semin Oncol. 2004 Apr;31(2 Suppl 6):30-6. Review.

PMID:
15176002
4.

Molecular targeting of dermatofibrosarcoma protuberans: a new approach to a surgical disease.

McArthur GA.

J Natl Compr Canc Netw. 2007 May;5(5):557-62. Review.

PMID:
17509258
5.

Targeted therapy for dermatofibrosarcoma protuberans.

Abrams TA, Schuetze SM.

Curr Oncol Rep. 2006 Jul;8(4):291-6. Review.

PMID:
17254529
6.

Dermatofibrosarcoma protruberans treatment with platelet-derived growth factor receptor inhibitor: a review of clinical trial results.

Malhotra B, Schuetze SM.

Curr Opin Oncol. 2012 Jul;24(4):419-24. doi: 10.1097/CCO.0b013e328353d78d. Review.

PMID:
22510939
7.

Imatinib mesylate for children with dermatofibrosarcoma protuberans (DFSP).

Gooskens SL, Oranje AP, van Adrichem LN, de Waard-van der Spek FB, den Hollander JC, van de Ven CP, van den Heuvel-Eibrink MM.

Pediatr Blood Cancer. 2010 Aug;55(2):369-73. doi: 10.1002/pbc.22494. Review.

PMID:
20582941
8.

[Dermatofibrosarcoma protuberans].

Sanmartín O, Llombart B, López-Guerrero JA, Serra C, Requena C, Guillén C.

Actas Dermosifiliogr. 2007 Mar;98(2):77-87. Review. Spanish.

PMID:
17397592
9.

Dermatofibrosarcoma protuberans: a surgical disease with a molecular savior.

McArthur GA.

Curr Opin Oncol. 2006 Jul;18(4):341-6. Review.

PMID:
16721128
10.

[Molecular approach in the treatment of dermatofibrosarcoma protuberans].

Fattoruso SI, Visca P, Lopez M.

Clin Ter. 2008 Sep-Oct;159(5):361-7. Review. Italian.

PMID:
18998038
11.

Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management.

Llombart B, Serra-Guillén C, Monteagudo C, López Guerrero JA, Sanmartín O.

Semin Diagn Pathol. 2013 Feb;30(1):13-28. doi: 10.1053/j.semdp.2012.01.002. Review.

PMID:
23327727
12.

A comprehensive review of imatinib mesylate (Gleevec) for dermatological diseases.

Scheinfeld N.

J Drugs Dermatol. 2006 Feb;5(2):117-22. Review. Erratum in: J Drugs Dermatol. 2006 Mar;5(3):table of contents. Schienfeld, Noah [corrected to Scheinfeld, Noah].

PMID:
16485879
13.

Current treatment options for dermatofibrosarcoma protuberans.

Rutkowski P, Debiec-Rychter M.

Expert Rev Anticancer Ther. 2015;15(8):901-9. doi: 10.1586/14737140.2015.1052799. Epub 2015 May 31. Review.

PMID:
26027711
14.

Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans.

Mizutani K, Tamada Y, Hara K, Tsuzuki T, Saeki H, Tamaki K, Matsumoto Y.

Br J Dermatol. 2004 Jul;151(1):235-7. Review. No abstract available.

PMID:
15270901
15.

Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment.

Sirvent N, Maire G, Pedeutour F.

Genes Chromosomes Cancer. 2003 May;37(1):1-19. Review.

PMID:
12661001
16.

Dermatofibrosarcoma protuberans: is mohs surgery truly superior? And the success of tyrosine kinase inhibitors.

Kallini JR, Khachemoune A.

J Drugs Dermatol. 2014 Dec;13(12):1474-7. Review.

PMID:
25607791
17.

Current treatment options in dermatofibrosarcoma protuberans.

Lemm D, Mügge LO, Mentzel T, Höffken K.

J Cancer Res Clin Oncol. 2009 May;135(5):653-65. doi: 10.1007/s00432-009-0550-3. Epub 2009 Feb 10. Review.

PMID:
19205737
18.

[Clinical studies with imatinib in 2004].

Eckhardt S.

Orv Hetil. 2005 May 1;146(18 Suppl 1):941-4. Review. Hungarian.

PMID:
15921309
19.

[Imatinib and solid tumours].

Arifi S, El Sayadi H, Dufresne A, Ray-Coquard I, Fayette J, Méeus P, Ranchère D, Decouvelaere AV, Alberti L, Tabone-Eglinger S, Blay JY, Cassier P.

Bull Cancer. 2008 Jan;95(1):99-106. doi: 10.1684/bdc.2008.0557. Review. French.

20.

Imatinib as effective therapy for dermatofibrosarcoma protuberans: proof of concept of the autocrine hypothesis for cancer.

Handolias D, McArthur GA.

Future Oncol. 2008 Apr;4(2):211-7. doi: 10.2217/14796694.4.2.211. Review.

PMID:
18407734

Supplemental Content

Support Center